| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $95K | -60.9% |
| R&D Expense | $242.9M | -5.3% |
| SG&A Expense | $71.7M | -9.6% |
| Operating Income | -$327.7M | +2.3% |
| Income Tax | $0 | — |
| Net Income | -$327.3M | +1.6% |
| EPS (Basic) | -$2.09 | +9.9% |
| EPS (Diluted) | -$2.09 | +9.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.2M | +34.3% |
| Current Assets | $459.1M | -13.2% |
| Total Assets | $642.8M | -21.3% |
| Current Liabilities | $37.1M | -32.0% |
| Total Liabilities | $130.6M | -13.6% |
| Stockholders' Equity | $512.2M | -23.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$237.7M | -7.8% |
| Capital Expenditures | $1.5M | -70.8% |
| Investing Cash Flow | $163.3M | +53.8% |
| Financing Cash Flow | $95.7M | +3143.9% |
| Free Cash Flow | -$239.2M | -6.0% |